Expression of transforming growth factor (TGF)-β1, -β2, and -β3 isoforms and TGF-β type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 2, 1999, Pages 174-187

  De Groot, Corline J A ^a   Montagne, Lisette ^c   Barten, Angeliqú D ^b   Sminia, Peter ^b   Van Der Valk, Paul ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NONE

Author keywords

Cell cultures; Hypertrophic astrocytes; Immunohistochemistry; Macrophages; Microglia; Multiple sclerosis; TGF bioassay

Indexed keywords

MESSENGER RNA; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MULTIPLE SCLEROSIS; NERVE CELL CULTURE; PRIORITY JOURNAL;

EID: 0033036761     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199902000-00007     Document Type: Article

References (54)

1. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992; 18:319-34
2. Ishikawa M, Tsukamoto T, Yamamoto Suppressive effects of TNF-α on myeline formation in vitro. Acta Neurol Scand 1996;2:91-95
3. Merrill JE, Strom SR, Ellison GW, Meyers LW. In vitro study of mediators of inflammation in multiple sclerosis. J Clin Immunol 1989;9:84-96
4. Da Cunha A, Jefferson JJ, Tyor WR, Glass JD, Jannotta FS, Vitkovic L. Control of astrocytosis by interleukin-1 and transforming growth factor-β1 in human brain. Brain Res 1993;631:39-45
5. Woodroofe MN, Cuzner ML. Cytokine mRNA expression in inflammatory multiple sclerosis: Detection by non-radioactive in situ hybridization. Cytokine 1993;5:583-88
6. Guilian D, Li J. Li X, Georg J, Rutecki PA. The impact of microglia-derived cytokines upon gliosis in the CNS. Dev Neurosci 1994;16:128-36
7. Cannella B, Raine CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995;37:424-35
8. Merrill JE, Benveniste EN. Cytokines in inflammatory brain lesions: Helpful and harmful. TINS 1996;19:331-38
9. Wahl SM. Transforming growth factor β: The good, the bad, and the ugly. J Exp Med 1994;180:1587-90
10. Paulus W, Baur I, Huettner C, Schmausser B, Roggendorf W, Schlingensiepen KH. Effects of transforming growth factor-beta I on collagen synthesis, integrin expression, adhesion and invasion of glioma cells. J Neuropathol Exp Neurol 1995;54:236-44
11. Kulkarni AB, Ward JM, Yaswen L, et al. Transforming growth factor-β1 Null Mice. An animal model for inflammatory disorders. Am J Pathol 1995;146:264-75
12. Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A. Differential expression of transforming growth factor-β1, -β2, and β3 by glioblastoma cells, astrocytes, and microglia. J Immunol 1992;148:1404-10
13. Stavnezer J. Regulation of antibody production and class switching by TGF-β. J Immunol 1995;155:1647-51
14. Cheifetz S, Massagué J. Isoform specific transforming growth factor-β binding proteins with membrane attachments sensitive to phosphotidylinositol-specific phospholipase C. J Biol Chem 1991; 266:20767-72
15. Franzén P, ten Dijke P, Ichijo H, et al. Cloning of a TGF beta type I receptor that forms a heterodimeric complex with the TGF beta type II receptor. Cell 1993;75:681-92
16. Kim DH, Kim S-J. Transforming growth factor-β receptors: Role in physiology and disease. J Biomed Sci 1996;3:143-58
17. Wrana JL, Attisano L, Carcamo J, et al. TGF beta signals through a heterodimeric protein kinase receptor complex. Cell 1992;71: 1003-14
18. Yamada N, Kato M, Yamashita H, et al. Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma. Int J Cancer 1995;62:386-92
19. Lopez CF, Wrana JL, Massague J. Beta-glycan presents ligand to the TGF-beta signalling receptor. Cell 1993;73:1435-44
20. Gold LI, Sung JJ, Siebert JW, Longaker MT. Type I (RI) and Type II (RII) receptors for transforming growth factor-β isoforms are expressed subsequent to transforming growth factor-β ligands during excisional wound repair. Am J Pathol 1997;150:209-22
21. Ignotz RA, Massagué J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-45
22. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. The New Engl J Med 1994;10:1286-91
23. Flanders KC, Roberts AB, Ling N, Fleurdelys BE, Sporn MB. Antibodies to peptide determinants in transforming growth factor β and their applications. Biochem 1988;27:739-46
24. Flanders KC, Thompson NL, Cissel DS, et al. Transforming growth factor-β1: Histochemical localization with antibodies to different epitopes. J Cell Biol 1989;108:653-60
25. Barcellos-Hoff MH, Ehrhart EJ, Kalia M, Jirtle R, Flanders KC, Tsang ML-S. Immunohistochemical detection of active transforming growth factor-β in situ using engineered tissue. Am J Pathol 1995;147:1228-37
26. Pulford KA, Rigney EM, Micklem KJ, et al. KP1: A new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989;42: 414-21
27. Zwadlo G, Bröckner EB, Bassewitz BD, Feige U, Sorg C. A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J. Immunol 1985; 134:1487-92
28. De Groot CJA, Langeveld CH, Jongenelen CAM, Montagne L, Van der Valk P, Dijkstra CD. Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: Immunophenotypical and functional characterization. J Neurosci Res 1997;49:342-54
29. De Groot CJA, Ruuls SR, Theeuwes JWM, Dijkstra CD, Van Der Valk P. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 1997;56:10-20
30. De Groot CJA, Sminia T, Dijkstra CD. Isolation and characterization of brain macrophages from the central nervous system of newborn and adult rats and of rats with experimental allergic encephalomyelitis. Immunobiol 1989;179:314-27
31. De Groot CJA, Theeuwes JWM, Dijkstra CD, Van Der Valk P. Postmortem delay effects on neuroglial cells and brain macrophages from Lewis rats with acute experimental allergic encephalomyelitis: An immunohistochemical and cytochemical study. J Neuroimmunol 1995;59:123-34
32. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB. An assay for transforming growth factor-β using cells transfected with a plaminogen activator inhibitor-1 promotor-luciferase construct. Anal Biochem 1994;216:276-84
33. Van Waarde MAWH, Van Assen AJ, Kampinga HH, Konings ATW, Vujaskovic Z. Quantification of transforming growth factor-β in biological material using cells transfected with plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 1997;247:45-51
34. Sminia P, Barten AD, Van Waarde MAWH, Vujaskovic Z, Van Tienhoven G. Plasma transforming growth factor levels in breast cancer patients. Oncol Reports 1998;5:485-88
35. Kaashoek JGJ, Mout R, Falkenburg JHF, Willemze R, Fibbe WE, Landegent JF. Cytokine production by the bladder carcinoma cell line 5637: Rapid analysis of mRNA expression level, using a cDNA-PCR procedure. Lymphokine Cytokine Res 1991;10:231-35
36. McCaffrey TA, Consigli S, Du BH, et al. Decreased type-II, type-I TGF-beta receptor ratio in cells derived from human atherosclerotic lesion-conversion from an anti-proliferative to pro-fibrotic response to TGF-beta-1. J Clin Invest 1995;96:2667-75
37. Sillekens PTG, Habets WJ, Beijer RP, Venrooij WJ. cDNA cloning of the human U1 snRNA-associated A protein: Extensive homology between U1 and U2 snRNA-specific proteins. EMBO J 1987;6: 3841-48
38. Cossins JA, Clements JM, Ford J, Miller MM, et al. Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol 1997;94:590-98
39. Peress NS, Perillo E, Seidman RJ. Glial transforming growth factor (TGF)-β isotypes in multiple sclerosis: Differential glial expression of TGF-β1.2 and 3 isotypes in multiple sclerosis. J Neuroimmunol 1996;71:115-23
40. Reilly JF, Maher PA, Kumari VG. Regulation of Astrocyte GFAP Expression by TGF-β1 and FGF-2. Glia 1998;22:202-10
41. Esiri MM, Morris CS. Immunocytochemical study of macrophages and microglia cells and extracellular matrix components in human CNS disease: 2. Non-neoplastic diseases. J Neurol Sci 1991;101: 59-72
42. Sobel RA, Mitchell ME. Fibronectin in multiple sclerosis. Am J Pathol 1989;135:161-68
43. Van der Laan LJW, De Groot CJA. Elices MJ, Dijkstra CD. Extracellular matrix proteins expressed by human adult astrocytes in vivo and in vitro: An astrocyte surface protein containing the CS1 domain contributes to binding of lymphoblasts. J Neurosci Res 1997; 50:539-48
44. Vincent VAM, Tilders FJH, Van Dam A-M. Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: A role for transforming growth factor β. Glia 1997;19:190-98
45. Johnson MD, Gold LI. Distribution of transforming growth factor-β isoforms in human immunodeficiency virus-1 encephalitis. Human Pathol 1995;27:643-49
46. Wahl SM, Allen JB, McCartney-Francis N, Morganti-Kossmann MC, et al. Macrophage and astrocyte-derived transforming growth factor-β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 1991;173:981-91
47. Flanders KC, Lippa CF, Smith TW, Pollen DA, Sporn MB. Altered expression of transforming growth factor-β in Alzheimer's disease. Neurol. 1995;45:1561-69
48. Peress NS, Perillo E. Differential expression of TGF-β1, 2 and 3 isotypes in Alzheimer's disease: A comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J Neuropathol Exp Neurol 1995;54:802-11
49. Link J, Fredrikson S, Soderstrom M, et al. Organ-specific autoantigens induce transforming growth factor-β mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Ann Neurol 1994;35:197-203
50. Link J, Söderström M, Olsson T, Höjeberg B, Ljungdahl Å, Link H. Increased transforming growth factor-β, interleukin-4 and interferon-γ in multiple sclerosis. Ann Neurol 1994;36:379-86
51. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993;151:2132-41
52. Hurwitz AA, Lyman WD, Berman JW. Tumor necrosis factor-α and transforming growth factor-β upregulate astrocyte expression of MCP-1. J Neuroimmunol 1985;57:193-98
53. Wyss-Coray T, Feng L, Masliah E, et al. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Am J Pathol 1995;147:53-67
54. Ata AK, Funa K, Olsson Y. Expression of various TGF-β isoforms and type I receptor in necrotizing human brain lesions. Acta Neuropathol 1997;93:326-33